Covance has signed a definitive agreement with Lilly to help transform Lilly’s R&D model. Under the agreement, Covance will acquire Lilly’s 450-acre early drug development campus in Greenfield, IN for $50 million and will offer employment to about 260 Lilly employees.  In addition, Covance will provide Lilly with a broad-range of drug development services during the next 10 years for a contract value of $1.6 billion. Covance will assume ownership of the site and operations in October.   Li...